文献速递产科妇科

妊娠期宫颈癌筛查异常后失访的相关因素

Factors associated with loss to follow up after abnormal cervical cancer screening in pregnancy.
PubMed 文献 · Gynecol Oncol · 2024-02-17

本研究在一家城市安全网医院的人群中,评估妊娠期宫颈细胞学异常转诊阴道镜检查后失访的风险因素。共识别1063例患者,40.8%完成转诊阴道镜检查。转诊时母亲年龄>30岁、细胞学异常时孕周<18周、非非洲裔美国人种族及高级别宫颈细胞学与完成随访相关;年轻母亲年龄、非洲裔美国人种族、较晚孕周完成细胞学及低级别初始细胞学与失访相关。

要点

  • 1063例中仅40.8%完成转诊阴道镜检查,妊娠期异常宫颈细胞学随访不足突出。
  • 母亲年龄>30岁、孕周<18周、非非洲裔美国人、高级别细胞学与完成随访相关。
  • 非洲裔美国人患者未就诊率更高,支持健康差异需进一步调查和方案识别失访风险者。

核心结论

  • 在该人群中,妊娠期异常宫颈细胞学随访不足突出,尤其见于年轻母亲年龄、非洲裔美国人种族、较晚孕周完成宫颈细胞学及低级别初始细胞学者。
  • 非洲裔美国人患者未就诊率更高支持健康差异,需进一步调查和方案以识别失访风险者。

研究设计与样本

  • 研究在一家城市阴道镜中心查询妊娠期及产后因异常宫颈细胞学转诊随访的患者,通过电子病历标准化转诊代码识别。
  • 共识别1063例患者,采用多变量逻辑回归比较完成阴道镜随访与失访患者的特征。
  • 评估的独立风险因素包括年龄、产次、种族、保险、HIV状态、精神疾病史、BMI、筛查时孕周和孕期、转诊阴道镜时细胞学、至阴道镜间隔天数及活检组织学。

主要发现

  • 1063例患者中40.8%完成转诊阴道镜检查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess risk factors associated with loss to follow up in patients referred for colposcopy after abnormal cervical cytology during pregnancy in a Southern safety net hospital population. METHODS: An urban colposcopy center was queried for patients referred for follow up of abnormal cervical cytology during pregnancy and the postpartum period. Patients were identified through a standardized referral code in the electronic medical record. Multivariable logistic regression was used to compare patient characteristics between those who followed up for colposcopy and those lost to follow up. Independent risk factors assessed included age, parity, race, insurance, HIV status, history of mental illness, BMI, gestational age and trimester at screening, cytology at colposcopy referral, interval days until colposcopy, and biopsy histology. RESULTS: 1063 patients were identified, with 40.8% of patients who completed referred colposcopy. Patient characteristics predictive for colposcopy follow up included: maternal age at referral cervical cytology >30 years (1.67; 1.27-2.20; < 0.003), gestational age < 18 weeks at abnormal cervical cytology (1.57; 1.23-2.01; <0.0002), maternal race non-African American (2.20; 1.32-3.65; <0.0024) and with high grade cervical cytology (2.42; 1.81-3.24; <0.0001). CONCLUSION: In this population, inadequate follow up for abnormal cervical cytology during pregnancy is prominent, especially among those with younger maternal age, African American (AA) race, cervical cytology completed at later gestational ages of pregnancy, and low-grade initial cytology. Higher no-show rate among AA patients supports well-documented health disparities and need for further investigation and protocols to identify those at risk for loss to follow up.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Roof KA, Wichmann HK, Carlton LJ, et al. Factors associated with loss to follow up after abnormal cervical cancer screening in pregnancy. Gynecol Oncol. 2024. PMID: 38368812. doi:10.1016/j.ygyno.2024.01.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。